PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM)
CUSIP: 70387R403
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 6,367,621
- Total 13F shares
- 1,535,145
- Share change
- +310,314
- Total reported value
- $662,767
- Price per share
- $0.43
- Number of holders
- 32
- Value change
- +$133,813
- Number of buys
- 13
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 70387R403?
CUSIP 70387R403 identifies PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 70387R403:
Top shareholders of PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC |
13D/G
|
— |
9.9%
|
1,226,316
|
$858,421 | $0 | 31 Dec 2024 | |
| Sargent Investment Group, LLC |
13D/G
|
— |
5.8%
|
1,006,300
|
$604,183 | $0 | 01 Jul 2025 | |
| FIRST MANHATTAN CO. LLC. |
13D/G
13F
|
Company |
4.3%
|
714,100
|
$499,870 | $0 | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
88,680
|
$53,244 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
81,494
|
$48,896 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.1%
|
72,660
|
$43,618 | — | 30 Jun 2025 | |
| James L. Cox |
3/4/5
|
Director |
—
class O/S missing
|
65,000
|
$40,508 | — | 22 Feb 2024 | |
| Joan B. Harvey |
3/4/5
|
Director |
—
class O/S missing
|
65,000
|
$40,508 | — | 22 Feb 2024 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
1%
|
65,047
|
$39,048 | — | 30 Jun 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.87%
|
55,531
|
$33,335 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.83%
|
52,676
|
$31,621 | — | 30 Jun 2025 | |
| Obermeyer Wealth Partners |
13F
|
Company |
0.34%
|
21,500
|
$12,906 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.33%
|
20,854
|
$12,519 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
11,706
|
$7,027 | — | 30 Jun 2025 | |
| XML Financial, LLC |
13F
|
Company |
0.16%
|
10,067
|
$6,043 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.14%
|
8,751
|
$5,250 | — | 30 Jun 2025 | |
| CWM, LLC |
13F
|
Company |
0.1%
|
6,412
|
$4,000 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
5,026
|
$3,017 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.07%
|
4,490
|
$2,695 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.04%
|
2,481
|
$1,489 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
1,444
|
$867 | — | 30 Jun 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.01%
|
836
|
$502 | — | 30 Jun 2025 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
295
|
$178 | — | 30 Jun 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
246
|
$148 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
159
|
$95 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
108
|
$65 | — | 30 Jun 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
95
|
$57 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
74
|
$44 | — | 30 Jun 2025 | |
| ELEVATION POINT WEALTH PARTNERS, LLC |
13F
|
Company |
0%
|
34
|
$20 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
30
|
$18 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
18
|
$11 | — | 30 Jun 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
12
|
$7 | — | 30 Jun 2025 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0%
|
5
|
$3 | — | 30 Jun 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Jun 2025 | |
| Brian J. DeGuzman |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
50,000
|
— | — | 18 Feb 2022 |
Institutional Holders of PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) as of Q3 2025
As of 30 Sep 2025,
PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,535,145 shares.
The largest 10 holders included
FIRST MANHATTAN CO. LLC., VANGUARD GROUP INC, JANE STREET GROUP, LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., CAPTRUST FINANCIAL ADVISORS, LPL Financial LLC, NORTHERN TRUST CORP, Virtu Financial LLC, and Obermeyer Wealth Partners.
This page lists
32
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
29
Q3 2025 holders
32
Holder diff
3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.